Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 101–101 of 101 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02247453	Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study(BIOMILD)	active not recruiting	N/A	4,119	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Mar 7, 2024	clinicaltrials